EUVIMEDEUVIMED entdecken
Crossref

Respiratory Syncytial Virus Infection Disrupts Airway Epithelial Barriers via IL‐33/ST2/MyD88 Signaling Axis

Qing Miao iD, Rui Yu, Fanyu Shi, Kaixin Li, Xinqian Du, Yinuo Gao, Yan Li, Ye Cui, Yan Chen, Jie Liu, Zhe Lv, Jing Yuan und 3 weitere

Journal of Medical Virology · 2025-06 · 97 (6)

DOI: 10.1002/jmv.70432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 11.06.2025. Verfasst von Qing Miao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Viruses, Signal Transduction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: The work was supported by the National Natural Science Foundation of China (82471813, 82350710228, 82071805, 81971510), and the Beijing Natural Science Foundat….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) infection has been associated with disruption of the airway epithelial barrier, potentially increasing the risk of asthma development. However, whether and how RSV and RSV‐induced IL‐33 contribute to this process are still unclear. In vivo, 7‐day‐old C57BL/6 mice were infected perinasally with RSV, then viral replication, lung inflammation and barrier integrity were evaluated at various time points postinfection. In vitro, human epithelial cells were infected with RSV in the presence or absence of IL‐33, and the expression and localization of apical junction complex proteins (AJC) were assessed by western blot analysis and immunofluorescence staining. The involvement of components of the IL‐33/ST2/MyD88 axis was further verified through blockade of endogenous IL‐33 signaling and pharmacological inhibition of MyD88. Exposure to RSV infection resulted in impairment of the airway epithelial barrier, as indicated by reduced expression of tight junction proteins (ZO‐1, Occludin) and adherents junction protein (E‐cadherin) in the lung tissues. These effects on epithelial barrier disruption were significantly attenuated in St2 ‐/‐ mice compared with wild‐type controls. In vitro, the RSV‐induced epithelial barrier disruption was exacerbated by topical application of exogenous IL‐33, partially through activation of MyD88‐mediated NF‐κB signaling. Notably, knockdown of St2 by siRNA transfection or pharmacological inhibition of MyD88 partially restored the expression of E‐cadherin, ZO‐1 and Occludin in RSV‐infected epithelial cells. RSV infection triggers robust IL‐33 release from airway epithelial cells, leading to disrupted expression of AJC protein via activation of the MyD88‐dependent NF‐κB signaling pathway. These findings highlight the IL‐33/ST2/MyD88 axis as a critical mediator of epithelial barrier dysfunction, which may represent a potential target for therapeutic intervention in RSV‐mediated lung diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsRespiratory Syncytial VirusesSignal TransductionAnimalsMiceMice, Inbred C57BLDisease Models, AnimalLungHumansCell LineInflammationEpitheliumCytokinesInterleukin-33Myeloid Differentiation Factor 88NF-kappa B

Stichwörter der Autor:innen

IL‐33NF‐κBRSVST2epithelial barriertight junction

Substanzen

CytokinesInterleukin-33Myd88 protein, mouseMyeloid Differentiation Factor 88NF-kappa B

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • Department of Allergy, Children's National Medical Center, Beijing Children's Hospital, Capital Medical University, Key Laboratory of Pediatric Major Diseases Ministry of Education, National Clinical Medical Research Ce…
  • Department of Otorhinolaryngology Head and Neck Surgery, Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Beijing Institute of Otolaryngology, Beijing Key Laboratory of Nasal Disease, Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, Capital Medical University, Beijing, China.
  • Beijing Laboratory of Allergic Diseases, Beijing Municipal Education Commission, Beijing, China.
  • Department of Respiratory Medicine, Capital Medical University, Beijing, China.

ORCID-Profile: Qing Miao

Förderung

  • The work was supported by the National Natural Science Foundation of China (82471813, 82350710228, 82071805, 81971510), and the Beijing Natural Science Foundat…

Zitieren

APA

Miao, Q., Yu, R., Shi, F., Li, K., Du, X., Gao, Y., Li, Y., Cui, Y., Chen, Y., Liu, J., Lv, Z., Yuan, J., Corrigan, C. J., Ying, S., & Wang, W. (2025). Respiratory Syncytial Virus Infection Disrupts Airway Epithelial Barriers via IL‐33/ST2/MyD88 Signaling Axis. Journal of Medical Virology, 97(6). https://doi.org/10.1002/jmv.70432

Vancouver

Miao Q, Yu R, Shi F, Li K, Du X, Gao Y, et al. Respiratory Syncytial Virus Infection Disrupts Airway Epithelial Barriers via IL‐33/ST2/MyD88 Signaling Axis. Journal of Medical Virology. 2025;97(6). doi:10.1002/jmv.70432

BibTeX
@article{Miao2025,
  author = {Miao, Qing and Yu, Rui and Shi, Fanyu and Li, Kaixin and Du, Xinqian and Gao, Yinuo and Li, Yan and Cui, Ye and Chen, Yan and Liu, Jie and Lv, Zhe and Yuan, Jing and Corrigan, Chris J and Ying, Sun and Wang, Wei},
  title = {Respiratory Syncytial Virus Infection Disrupts Airway Epithelial Barriers via IL‐33/ST2/MyD88 Signaling Axis},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {6},
  doi = {10.1002/jmv.70432}
}
Kostenlos starten →